Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCyanconnode Regulatory News (CYAN)

Share Price Information for Cyanconnode (CYAN)

Share Price is delayed by 15 minutes
Get Live Data
7.80    -0.10 (-1.27%)
Bid:
7.60
Ask:
8.00
Spread: 0.40 (5.263%)
Market Cap: £27.46m
CYAN Live PriceLast checked at - London Stock Exchange

Intraday Cyanconnode Share Chart

Form 8 (Opening Position Disclosure) - Replacement

5 Mar 2026 16:17

RNS Number : 5614V
CyanConnode Holdings PLC
05 March 2026
 

Replacement: This announcement replaces the "CyanConnode Holdings plc - Form 8 (OPD)" announcement released at 12:52:13 on 17 February 2026 with RNS Number 3736T. The interests disclosed in respect of Peter Tyler, his close relatives and related trusts have been amended. All other information, save for the date of disclosure, remains unchanged.

 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

CyanConnode Holdings plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

CyanConnode Holdings plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

16 February 2026

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares of 2 pence each

("Ordinary Shares")

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

Nil

Nil

Nil

(2) Cash-settled derivatives:

 

Nil

Nil

Nil

Nil

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

Nil

Nil

Nil

 

TOTAL:

Nil

Nil

Nil

Nil

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

Directors' interests

a) Ordinary Shares held by the directors of CyanConnode Holdings plc, their close relatives and related trusts:

Director

Number of Ordinary Shares held

Percentage of total issued ordinary share capital

Peter Tyler and associated persons

21,199,227*

5.90

William David Johns-Powell

19,621,561

5.47

John Cronin

13,062,451**

3.64

Heather Peacock

2,822,966***

0.79

Bjorn Lindblom

912,377

0.25

Lyndon Faulkner

500,000

0.14

Notes:

* - includes 723,794 ordinary shares held by his daughter, Jessica Pullen; 4,407,556 shares held personally by his brother, Barrie Tyler, together with 13,224,837 shares held by Nathan Tyler and Simon Tyler (sons of Barrie Tyler) and their close relatives (excluding Barrie Tyler), who also hold 2,217,700 cash-settled derivatives; and 236,389 shares held by his brother Andrew Tyler, together with Andrew's wife, Sharon Tyler

** - includes 5,672,359 shares held jointly with the CyanConnode Holdings plc Employee Benefit Trust ("EBT") pursuant to a Joint Share Ownership Plan ("JSOP")

*** - includes 1,331,498 shares held jointly with the EBT pursuant to a JSOP

 

b) Ordinary Shares held by entities connected with the directors of CyanConnode Holding plc

 

Number of Ordinary Shares held

Percentage of total issued ordinary share capital

Albert E Sharp LLP *

2,279,241

0.63

Notes:

* - Albert E Sharp LLP is a firm in which Peter Tyler's brother, Barrie Tyler, is a partner, and exercises discretion over 2,279,241 of the 6,219,180shares held by the firm under discretion.

 

c) Options or awards granted under the share plans of CyanConnode Holdings plc held by the directors of CyanConnode Holdings plc, their close relatives and related trusts:

 

Name

Name of Share Option Scheme

Number of Options

Exercise Price

(£)

Grant Date

Vesting Date

Expiry Date

Vesting Status

William David Johns-Powell

Unapproved

250,000

0.1000

28/09/20

28/09/24

28/09/30

Vested

Heather Peacock

Unapproved

25,000

0.4000

11/12/17

11/12/21

11/12/27

Vested

Unapproved

90,909

0.1000

22/09/20

22/09/24

22/09/30

Vested

Unapproved

100,000

0.1575

17/11/23

17/11/23

17/11/33

Vested

Unapproved

100,000

0.1575

17/11/23

31/03/24

17/11/33

Vested

Unapproved

100,000

0.1575

17/11/23

31/03/25

17/11/33

Vested

Unapproved

68,021

0.1400

17/11/23

17/11/23

17/11/33

Vested

Unapproved

68,021

0.1400

17/11/23

31/03/24

17/11/33

Vested

Unapproved

68,023

0.1400

17/11/23

31/03/25

17/11/33

Vested

Unapproved

59,525

0.1700

17/11/23

31/01/24

17/11/33

Vested

Unapproved

59,525

0.1700

17/11/23

31/01/25

17/11/33

Vested

Unapproved

59,527

0.1700

17/11/23

31/01/26

17/11/33

Vested

EMI

266,291

0.1450

10/11/21

30/06/21

10/11/31

Vested

EMI

266,291

0.1450

10/11/21

30/06/22

10/11/31

Vested

EMI

266,293

0.1450

10/11/21

30/06/23

10/11/31

Vested

EMI

206,474

0.1450

10/11/21

30/06/21

10/11/31

Vested

EMI

206,474

0.1450

10/11/21

30/06/22

10/11/31

Vested

EMI

206,476

0.1450

10/11/21

30/06/23

10/11/31

Vested

John Cronin

EMI

200,000

0.2960

25/01/18

25/01/22

25/01/28

Vested

EMI

360,342

0.1000

22/09/20

22/09/24

22/09/30

Vested

Unapproved

200,000

0.1575

17/11/23

17/11/23

17/11/33

Vested

Unapproved

200,000

0.1575

17/11/23

31/03/24

17/11/33

Vested

Unapproved

200,000

0.1575

17/11/23

31/03/25

17/11/33

Vested

Unapproved

168,694

0.1400

17/11/23

17/11/23

17/11/33

Vested

Unapproved

168,694

0.1400

17/11/23

31/03/24

17/11/33

Vested

Unapproved

168,694

0.1400

17/11/23

31/03/25

17/11/33

Vested

Unapproved

147,619

0.1700

17/11/23

31/01/24

17/11/33

Vested

Unapproved

147,619

0.1700

17/11/23

31/01/25

17/11/33

Vested

Unapproved

147,619

0.1700

17/11/23

31/01/26

17/11/33

Vested

EMI

196,345

0.1450

10/11/21

30/06/21

10/11/31

Vested

EMI

196,345

0.1450

10/11/21

30/06/22

10/11/31

Vested

EMI

196,347

0.1450

10/11/21

30/06/23

10/11/31

Vested

EMI

186,034

0.1450

10/11/21

30/06/21

10/11/31

Vested

EMI

186,034

0.1450

10/11/21

30/06/22

10/11/31

Vested

EMI

186,034

0.1450

10/11/21

30/06/23

10/11/31

Vested

Unapproved

315,689

0.0950

10/10/24

10/10/28

10/10/34

Unvested*

Lyndon Faulkner

EMI

474,833

0.1053

11/11/24

01/11/25

11/11/34

Unvested

EMI

474,833

0.1053

11/11/24

01/11/26

11/11/34

Unvested

EMI

474,833

0.1053

11/11/24

01/11/27

11/11/34

Unvested

EMI

474,836

0.1053

11/11/24

01/11/28

11/11/34

Unvested*

EMI

500,000

0.0994

20/11/24

20/11/28

20/11/34

Unvested*

Peter Tyler

Unapproved

40,000

0.1000

22/09/20

22/09/24

22/09/30

Vested

 

 

Notes:

* - these unvested options include provisions accelerating vesting on a change of control.

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

5 March 2026

Contact name:

Heather Peacock, Chief Financial Officer

Telephone number:

+44 (0)1223 865 750

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEJAMFTMTBMBTF
Date   Source Headline
19th Dec 20237:00 amRNSInterim Results
6th Dec 20231:32 pmRNSChange of Registered Office
1st Dec 20234:18 pmRNSHolding(s) in Company
21st Nov 20232:31 pmRNSHolding(s) in Company
20th Nov 20236:14 pmRNSIssue of Share Options – Correction
20th Nov 20237:00 amRNSNamed as One of the Fastest Growing Companies
17th Nov 20233:45 pmRNSDirector Option Grants
17th Nov 20238:30 amRNSHolding(s) in Company
16th Nov 202312:48 pmRNSHolding(s) in Company
15th Nov 20237:00 amRNSRanked 2nd Fastest-Growing UK Company in India
13th Nov 20236:11 pmRNSPlacing and Subscription – update
9th Nov 20238:02 amRNSResult of Oversubscribed Placing and Subscription
8th Nov 20235:24 pmRNSProposed Placing and Subscription to Raise c.£2.5m
31st Oct 20237:15 amRNSContract in the Middle East and North Africa
10th Oct 20237:00 amRNSOrder for 300,000 Omnimesh Modules
5th Oct 20237:00 amRNSTrading Update
24th Aug 202312:18 pmRNSResult of AGM
17th Aug 20231:00 pmRNSHolding(s) in Company
15th Aug 20237:00 amRNS2023 Annual General Meeting
4th Aug 20235:34 pmRNSDirector Dealing
2nd Aug 20237:00 amRNSOrder for 300,000 Omnimesh Modules
26th Jul 20235:34 pmRNSCorrection: Final Results
26th Jul 20237:00 amRNSFinal Results
25th Jul 20237:00 amRNSNotice of Results & Investor Presentation
6th Jul 20237:00 amRNSTrading Update
22nd Jun 20237:00 amRNSCyanConnode India is a Start-Up 50 Trailblazer
25th May 20238:10 amRNSOrder for 600,000 Omnimesh Modules
9th May 20233:45 pmRNSHolding(s) in Company
17th Apr 20237:00 amRNSInterview with MD & CEO for CyanConnode India
3rd Apr 20237:00 amRNSCyanConnode and Alfanar Sign MOU for AMI projects
21st Mar 20237:15 amRNSHardman Research - Acceleration and revenue uplift
13th Mar 20237:00 amRNSCyanConnode Banking Arrangements
7th Mar 20237:00 amRNSCollaboration with Silicon Laboratories
6th Mar 20237:00 amRNSAppointment of Nominated and Financial Adviser
6th Feb 20238:51 amRNSStrategic Framework Agreement - Replacement
6th Feb 20238:21 amRNSStrategic Framework Agreement
6th Feb 20237:00 amRNSStrategic Framework Agreement
31st Jan 20237:00 amRNSHolding(s) in Company
24th Jan 20238:00 amRNSResult of Oversubscribed Placing and Subscription
23rd Jan 20235:11 pmRNSProposed Placing and Subscription
19th Jan 20237:00 amRNSChange of Adviser
4th Jan 20237:00 amRNSOrder From New Partner
14th Dec 20227:00 amRNSInterim results
8th Dec 20227:00 amRNSInvestor Presentation
1st Dec 20227:00 amRNSTrading Update and Notice of Results
9th Nov 20227:00 amRNSHardman & Co - Indian smart meter programme update
27th Oct 20227:00 amRNSConference of Indian Power Ministers
25th Oct 20227:00 amRNSHolding(s) in Company
18th Oct 20226:12 pmRNSApplication to List Shares
18th Oct 20227:00 amRNSShare Subscription

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.